Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of October 17, 2012
  • Print
  • Share
  • E-mail
-
Back to Previous Page

Product Detail

Product Description Source Plasma
Recall Number B-2164-12
Classification Class II
Code Info 4180295780, 4180294894, 4180293744, 4180283593, 4180282892, 4180281202, 4180280604, 4180278570, 4180277820, 4180276612, 4180274515, 4180263406, 4180260842, 4180260079, 4180256240, 4180253464, 4180249029, 4180247557, 4180246771, 4180244936, 4180242533, 4180239378, 4180238122, 4180234049, 4180232196, 4180230162, 4180228498, 4180201425, 4180199340, 4180196842, 4180195554, 4180194508, 4180192034, 4180189396, 4180188420, 4180187221, 4180186479, 4180185283, 4180184637, 4180183187, 4180182484
Product Distributed Qty 41 units
Reason For Recall Blood products, collected from a donor whose physical examination was incomplete, were distributed.

Event Detail

Event Id 49260
Product Type Biologics
Status Terminated
Recalling Firm CSL Plasma, Inc
City Charlotte
State NC
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2008-05-30
Initial Firm Notification of Consignee or Public Other
Distribution Pattern IL & Switzerland
-
-